|
⚲
|
| Keyboard |
| Michal Silverberg | |
|---|---|
| Firm | |
| Address | Averna Therapeutics 134 Coolidge Avenue Watertown, MA 10022 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| ONL Therapeutics Inc | 021-524116 | Director | 60.0 M of 65.0 M |
||
| Averna Therapeutics Inc | 021-510828 | Director | 85.0 M of 85.0 M |
||
| Capstan Therapeutics Inc | 021-508077 | Director | 87.5 M of 175.0 M |
||
| Capstan Therapeutics Inc | 021-508076 | Director | 76.5 M of 102.0 M |
||
| Capstan Therapeutics Inc | 021-508075 | Director | 63.0 M of 63.0 M |
||
| Fore US Bio Inc | 021-490554 | Director | 62.1 M of 122.6 M |
||
| Redona Therapeutics Inc | 021-488348 | Director | 6.0 M of 11.9 M |
||
| Immpact Bio USA Inc | 021-430160 | Director | 139.9 M of 141.8 M |
||
| Immpact Bio USA Inc | 021-372570 | Director | 3.8 M of 5.5 M |
||
| Adicet Bio Inc | 021-350688 | Director | 80.0 M of 80.0 M |
||
| Galera Therapeutics Inc | 021-321456 | Director | 70.2 M of 70.2 M |
||
| Redona Therapeutics Inc | 021-320722 | Director | 60.8 M of 76.9 M |
||